Literature DB >> 32243811

The Chemical Biology of Ferroptosis in the Central Nervous System.

Rajiv R Ratan1.   

Abstract

Over the past five decades, thanatology has come to include the study of how individual cells in our bodies die appropriately and inappropriately in response to physiological and pathological stimuli. Morphological and biochemical criteria have been painstakingly established to create clarity around definitions of distinct types of cell death and mechanisms for their activation. Among these, ferroptosis has emerged as a unique, oxidative stress-induced cell death pathway with implications for diseases as diverse as traumatic brain injury, hemorrhagic stroke, Alzheimer's disease, cancer, renal ischemia, and heat stress in plants. In this review, I highlight some of the formative studies that fostered its recognition in the nervous system and describe how chemical biological tools have been essential in defining events necessary for its execution. Finally, I discuss emerging opportunities for antiferroptotic agents as therapeutic agents in neurological diseases.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATF4; Chac1; Erk signaling; HIF prolyl hydroxylases; N-acetylcysteine; Nrf-2; Trib3; adaptaquin; c-Myc; cystine transport; ferroptosis; glutathione; glutathione peroxidase-4; iron; mithramycin; reactive lipid species; transglutaminase

Mesh:

Year:  2020        PMID: 32243811      PMCID: PMC7245561          DOI: 10.1016/j.chembiol.2020.03.007

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  168 in total

Review 1.  Oxygen(es) and the hypoxia-inducible factor-1.

Authors:  R H Wenger; M Gassmann
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

2.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

3.  Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.

Authors:  Magdy Selim; Lydia D Foster; Claudia S Moy; Guohua Xi; Michael D Hill; Lewis B Morgenstern; Steven M Greenberg; Michael L James; Vineeta Singh; Wayne M Clark; Casey Norton; Yuko Y Palesch; Sharon D Yeatts
Journal:  Lancet Neurol       Date:  2019-03-18       Impact factor: 44.182

4.  Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor.

Authors:  M Yonezawa; S A Back; X Gan; P A Rosenberg; J J Volpe
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

5.  Cystamine improves functional recovery via axon remodeling and neuroprotection after stroke in mice.

Authors:  Pei-Cheng Li; Yun Jiao; Jie Ding; Yu-Chen Chen; Ying Cui; Cheng Qian; Xiang-Yu Yang; Sheng-Hong Ju; Hong-Hong Yao; Gao-Jun Teng
Journal:  CNS Neurosci Ther       Date:  2014-11-27       Impact factor: 5.243

6.  Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress.

Authors:  T H Murphy; M J De Long; J T Coyle
Journal:  J Neurochem       Date:  1991-03       Impact factor: 5.372

7.  Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke.

Authors:  Ishraq Alim; Joseph T Caulfield; Yingxin Chen; Vivek Swarup; Daniel H Geschwind; Elena Ivanova; Javier Seravalli; Youxi Ai; Lauren H Sansing; Emma J Ste Marie; Robert J Hondal; Sushmita Mukherjee; John W Cave; Botir T Sagdullaev; Saravanan S Karuppagounder; Rajiv R Ratan
Journal:  Cell       Date:  2019-05-02       Impact factor: 41.582

8.  Neuroprotective effects of sulforaphane after contusive spinal cord injury.

Authors:  Andrea L Benedict; Andrea Mountney; Andres Hurtado; Kelley E Bryan; Ronald L Schnaar; Albena T Dinkova-Kostova; Paul Talalay
Journal:  J Neurotrauma       Date:  2012-09-20       Impact factor: 5.269

Review 9.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

Authors:  Giles E Hardingham; Hilmar Bading
Journal:  Nat Rev Neurosci       Date:  2010-09-15       Impact factor: 34.870

Review 10.  Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.

Authors:  Pranavi Koppula; Yilei Zhang; Li Zhuang; Boyi Gan
Journal:  Cancer Commun (Lond)       Date:  2018-04-25
View more
  34 in total

1.  Identification of Ferroptotic Genes in Spinal Cord Injury at Different Time Points: Bioinformatics and Experimental Validation.

Authors:  Yu Kang; Qiangwei Li; Rui Zhu; Shuang Li; Xin Xu; Xuanming Shi; Zongsheng Yin
Journal:  Mol Neurobiol       Date:  2022-07-07       Impact factor: 5.682

Review 2.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

3.  Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ1-42-induced Alzheimer's disease mice and glutamate-injured HT22 cells.

Authors:  Sixia Yang; Zeping Xie; Tingting Pei; Yi Zeng; Qiaowu Xiong; Hui Wei; Yong Wang; Weidong Cheng
Journal:  Chin Med       Date:  2022-07-04       Impact factor: 4.546

4.  Hemin-Induced Death Models Hemorrhagic Stroke and Is a Variant of Classical Neuronal Ferroptosis.

Authors:  Marietta Zille; Juan A Oses-Prieto; Sara R Savage; Saravanan S Karuppagounder; Yingxin Chen; Amit Kumar; John H Morris; Karl A Scheidt; Alma L Burlingame; Rajiv R Ratan
Journal:  J Neurosci       Date:  2022-01-05       Impact factor: 6.709

5.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

6.  Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of TP53.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-14       Impact factor: 11.205

Review 7.  Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases.

Authors:  Orjon Rroji; Amit Kumar; Saravanan S Karuppagounder; Rajiv R Ratan
Journal:  Neurobiol Dis       Date:  2020-10-28       Impact factor: 5.996

Review 8.  Role of Ferroptosis in Stroke.

Authors:  Yunfei Xu; Kexin Li; Yao Zhao; Lin Zhou; Ying Liu; Jie Zhao
Journal:  Cell Mol Neurobiol       Date:  2022-01-31       Impact factor: 5.046

9.  Defining a pharmacological inhibitor fingerprint for oxytosis/ferroptosis.

Authors:  David Soriano-Castell; Antonio Currais; Pamela Maher
Journal:  Free Radic Biol Med       Date:  2021-05-16       Impact factor: 8.101

Review 10.  Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases.

Authors:  Pamela Maher; Antonio Currais; David Schubert
Journal:  Cell Chem Biol       Date:  2020-11-10       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.